Using LOINC for Clinical Trials Lab Test Submissions
|
|
- Bonnie Franklin
- 6 years ago
- Views:
Transcription
1 Using LOINC for Clinical Trials Lab Test Submissions Armando Oliva, M.D. Associate Director for Informatics CDER Office of Computational Science Ana Szarfman, M.D., Ph.D. Medical Officer, Data Mining Team CDER Office of Translational Sciences
2 The views expressed in this presentation are those of the speakers and not necessarily those of the Food and Drug Administration
3 Agenda Challenges analyzing lab data What is the LOINC? Why use the LOINC for lab tests? How do we move forward?
4 Challenges Analyzing Lab Data Laboratory data are not always poolable by test within an application or across applications e.g serum glucose, urine glucose Specimen (LBSPEC) variable can help distinguish these two But certain automated tools only look at lab test name
5 Challenges (cont d) SDTM includes support for standardized results but the rules for standardization are neither clear nor adequately followed Results for a test are reported in more than one unit in the standardized variable Normal ranges are incomplete and/or incorrect, and submitted without High and Low values Detected multiple High and Low values ranges being zero
6 Challenges (cont d) Units for laboratory values and other measurements need to be consistent Specify standard units by test, specimen source, and other measurements Support an automated inter-unit conversion system Automate validation by reviewing outliers, and comparing the distribution of results
7 Challenges (cont d) CDISC controlled terminology allows multiple value domains for the same test Total Protein value domain depends on specimen and/or method (continuous for blood chemistry, ordinal for urinalysis) Need to use different test names for tests with different value domains or Modify the metadata model to clarify the use of test name within a classification system, including test, specimen, source, method and other differentiating characteristics This will help automate validation and discovery of aberrant results
8 What is the LOINC? Logical Observation Identifiers Names and Codes Widely used standard terminology for identifying and distinguishing clinical observations, including but not limited to laboratory tests International standard: User guide published in multiple languages (English, Chinese, German, Spanish, Turkish, Estonian) Free of charge
9 LOINC History Initiated by Dr. Clem MacDonald, Regenstrief Institute for Healthcare, in 1994 In response to demand for electronic movement of clinical data from laboratories to consumers of clinical data Sponsors: NLM, other government and private organizations Purpose is to facilitate the exchange and pooling of clinical data for clinical care, outcomes management, and research First release (v 1.0) was on 4/24/95
10 LOINC Scope Latest Version is 2.5 (released Dec 2014) 74,600 records Two sections Laboratory portion (49,528 records) Standard test names and codes Includes chemistry, hematology, serology, microbiology (including parasitology and virology), toxicology Drugs and cell counts for blood smears and cerebrospinal fluids Antibiotic susceptibilities Clinical portion (25,072 records) Vitals signs, hemodynamics, intake/output, ECG, obstetric ultrasound, cardio echo, urologic imaging, pulmonary ventilator management, gastroendoscopic procedures, survey instruments, other
11 Current Use of LOINC American Clinical Laboratory Association (ACLA), recommended adopting LOINC by its members LabCorp Quest SmithKline Beecham (now part of Quest) Mayo Medical Labs, University of Colorado, Intermountain Healthcare, Kaiser Permanente, Clarian Health, Partners Healthcare System, Mayo Clinic, Dept. of Defense, VA, CDC, NAACCR, HIPAA, Blue Cross, Aetna HHS has adopted the LOINC for lab tests to support federal regulations governing the meaningful use of EHR technologies China, Switzerland, Spain, Canada, Mexico, Russia
12 How does the LOINC work? Think of a clinical observation as a question/answer pair LOINC provides the question Other terminologies provide the answer UCUM Serum glucose = 105 mg/dl Sputum culture = streptococcus pneumoniae LOINC SNOMED CT
13 LOINC Code Codes are unique and have no meaning Format is nnnnn-n where the last n is a mod 10 check digit Each LOINC record corresponds to a single test (for lab results) or panel (for lab orders) e.g. CBC (Complete Blood Count) is the order Results are hemoglobin, hematocrit, WBC Count, platelet count, etc. Includes long names, short names and synonyms
14 LOINC Lab Tests Each lab test has 6 parts: 1. Component: the name of the analyte, e.g. glucose, sodium 2. Property: e.g. mass concentration; substance concentration; catalytic activity 3. Time: is the measurement taken at a point in time or over a specified time interval? 4. Sample: specimen; e.g. blood, CSF, urine 5. Scale: e.g. quantitative, ordinal, nominal 6. Method: optional
15 Anatomy of a LOINC Code :Hepatitis B virus surface Ab:ACnc:Pt:Ser:Qn:EIA LOINC Code Hepatitis B virus surface Ab Component ACnc Pt Ser Qn EIA Property Measured Timing System Scale Method There are six major LOINC axes
16 Why consider LOINC for Lab Tests in Clinical Research? Currently, CDER supports CDISC/NCI terminology for lab test names. Two challenges: Immediate challenge: Controlled terms not granular enough, e.g. serum glucose and urine glucose map to the same term (glucose C ), leads to errors in pooling data (this can be fixed) Long-Term challenge: Terminology not aligned with healthcare (EHRs) or clinical laboratories, which use the LOINC. Presents mapping challenges due to different levels of granularity. Problem only increases over time as more and more research is conducted within EHRs
17 Why consider LOINC for Lab Tests? LOINC is a Meaningful use standard Adopted by HHS for use in EHRs Used by EHRs and clinical laboratories Widely used internationally Improve semantic interoperability (easier to pool lab data across studies and distinguish lab tests that are different) LBLOINC variable already exists in SDTM
18 Why is CDER considering the LOINC? Part of larger strategy to align CDER supported data standards with national HIT initiatives Prescription Drug User Fee Act Five (PDUFA V) Information Technology Plan (FY ) at DrugUserFee/ucm htm Section 4, Goal 3, Reduce the burden of regulation through alignment with existing health IT initiatives, laws, regulations, and mandates such as Executive Orders
19 Clinical Research & Healthcare Clinical Research and Healthcare processes and data are largely silo ed There is a an increasing need to integrate clinical research with healthcare to increase knowledge generation and enhance evidence-based medicine as part of a continuously learning health system Clinical research and healthcare should (many think will) integrate Using the same terminologies for clinical data will facilitate the integration Producers of clinical data (labs, hospitals, clinics) are adopting meaningful use standards, such as the LOINC Consumers of clinical data (e.g. FDA, other public health agencies) should support meaningful use standards as much as possible Institute of Medicine: Integrating Research and Practice: Health System Leaders Working Toward High-Value Care. Working-Toward-High-Value-Care.aspx Integrating Research into Health Care Systems: Executives' Views - Executives-Views.aspx
20 LOINC under the hood Let s examine LOINC in more detail How might LOINC fit in the current world of clinical research? How might we get there?
21 LOINC Glucose Example NCI Term: glucose (C ) Code Long Common Name Short Name Component Property Time Specimen Scale Method Glucose [Mass/volume] in Serum or Plasma Glucose SerPl-mCnc Glucose MCnc Pt Ser/Plas Qn Glucose [Mass/volume] in Serum or Plasma --10 hours fasting Glucose [Mass/volume] in Urine hours fasting Glucose p 10h fast SerPlmCnc Glucose^post 10H CFst MCnc Pt Ser/Plas Qn Glucose^post 12H CFst MCnc Pt Urine Qn Glucose p 12h fast Ur-mCnc Glucose [Mass/volume] in Capillary blood Glucose BldC-mCnc Glucose MCnc Pt BldC Qn Glucose [Mass/volume] in Cerebral spinal fluid Glucose CSF-mCnc Glucose MCnc Pt CSF Qn Glucose [Mass/volume] in Body fluid Glucose Fld-mCnc Glucose MCnc Pt Body fld Qn Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g glucose PO Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO Glucose 1H p 50 g Glc PO SerPl-mCnc Glucose 2H p 75 g Glc PO SerPl-mCnc Glucose^1H post 50 g glucose PO MCnc Pt Ser/Plas Qn Glucose^2H post 75 g glucose PO MCnc Pt Ser/Plas Qn Glucose [Moles/volume] in Serum or Plasma Glucose SerPl-sCnc Glucose SCnc Pt Ser/Plas Qn
22 LOINC and SDTM important differences exist in current representations LOINC Code LOINC SDTM LB Component Property Timing System Scale Method LBTEST LBTESTCD LBSPEC LBANTREG LBMETHOD LBLOINC ALKALINE PHOSPHATASE CCNC PT SER/PLAS QN Alkaline Phosphatase ALP SERUM, PLASMA ALKALINE PHOSPHATASE.BONE CCNC PT SER/PLAS QN Alkaline Phosphatase ALP SERUM, PLASMA Bone ALKALINE PHOSPHATASE.BONE/ALKALIN CFR PT SER/PLAS QN E PHOSPHATASE.TOTAL Alkaline Phosphatase ALP SERUM, PLASMA Bone ALKALINE PHOSPHATASE.INTESTINAL CCNC PT SER/PLAS QN Alkaline Phosphatase ALP SERUM, PLASMA Intestine ALKALINE PHOSPHATASE.INTESTINAL/AL KALINE PHOSPHATASE.TOTAL CFR PT SER/PLAS QN Alkaline Phosphatase ALP SERUM, PLASMA Intestine ALKALINE.PHOSPHATASE.LIVER CCNC PT SER/PLAS QN Alkaline Phosphatase ALP SERUM, PLASMA Liver ALKALINE PHOSPHATASE.LIVER/ALKALIN E PHOSPHATASE.TOTAL CFR PT SER/PLAS QN Alkaline Phosphatase ALP SERUM, PLASMA Liver
23 Potential Modifications to SDTM LB LOINC Code LOINC SDTM LB Component Property Timing System Scale Method LBTEST LBTESTCD LBSPEC LBANTREG LBMETHOD LBLOINC ALKALINE PHOSPHATASE CCNC PT SER/PLAS QN Alkaline Phosphatase ALP SERUM, PLASMA ALKALINE PHOSPHATASE.BONE CCNC PT SER/PLAS QN Alkaline Phosphatase ALP SERUM, PLASMA Bone ALKALINE PHOSPHATASE.BONE/ALKALIN E PHOSPHATASE.TOTAL CFR PT SER/PLAS QN Alkaline Phosphatase ALP SERUM, PLASMA Bone ALKALINE PHOSPHATASE.INTESTINAL CCNC PT SER/PLAS QN Alkaline Phosphatase ALP SERUM, PLASMA Intestine LOINC Code maps to LBLOINC Component maps to LBTEST System maps to LBSPEC Method maps to LBMETHOD Property, Timing, and Scale need new SDTM variables (Timing via existing CDISC timing variables(?), new LBPROP(?), new LBSCALE(?)) SDTM adopts LOINC controlled terminology for each LOINC part
24 LOINC - Challenges Extremely granular, e.g. serum glucose represented by many LOINC codes (fasting, random, finger stick, 2hr pp, etc.) Challenging to pick the right one consistently across organizations Some organizations define and implement a subset of LOINC to decrease coding variability Common or Preferred LOINC terms LOINC Top 2000 codes for Lab Results
25 LOINC - Benefits The increased granularity means Labs with the same LOINC codes are poolable Labs with different Properties have different LOINC codes and can be associated with different reporting units (e.g. Property = mass concentration (mg/dl) vs. Substance concentration (mmol/l)) Labs with different LOINC codes can be associated with different value domains (e.g. Total Protein, serum vs. Total Protein, urine)
26 How to move forward? Potential Path: Two Phases Phase 1 Minimal LOINC support: dip toe Encourage submitters to provide lab-generated LOINC code to populate SDTM LBLOINC (increase awareness, assess current coding variability, assess need for a LOINC subset; what would it look like?) Obtain public comment Phase 2 Full LOINC support: plunge Work with CDISC to modify SDTM, adopt LOINC terminology for LOINC parts Identify a LOINC subset of common or preferred terms to facilitate coding
27 Questions?
Logical Observations, Identifiers, Names and Codes (LOINC) Presented by Park Hyeungkeun
Logical Observations, Identifiers, Names and Codes (LOINC) Presented by Park Hyeungkeun 1 What will we cover today? LOINC structure and strategy Who is using LOINC Installing and Running RELMA Loading
More informationToward a Diagnosis Driven (Dental) Profession through Controlled Terminology
Toward a Diagnosis Driven (Dental) Profession through Controlled Terminology James J. Cimino, MD Director, Informatics Institute University of Alabama at Birmingham Birmingham, Alabama, USA Los Angeles,
More informationThe future of ODM. FH-Prof. Dr. Jozef Aerts University of Applied Sciences FH Joanneum Graz, Austria
The future of ODM FH-Prof. Dr. Jozef Aerts University of Applied Sciences FH Joanneum Graz, Austria History of the ODM Standard ODM = Operational Data Model XML-based standard for design, exchange, and
More informationSemantic Alignment between ICD-11 and SNOMED-CT. By Marcie Wright RHIA, CHDA, CCS
Semantic Alignment between ICD-11 and SNOMED-CT By Marcie Wright RHIA, CHDA, CCS World Health Organization (WHO) owns and publishes the International Classification of Diseases (ICD) WHO was entrusted
More informationSNOMED CT and Orphanet working together
SNOMED CT and Orphanet working together Ian Green Business Services Executive, IHTSDO Dr. Romina Armando INSERM Session outline What is Orphanet? Rare disorders Orphanet nomenclature Mappings to other
More informationHow to manage changes to CDISC standards at Novo Nordisk. PhUSE EU Connect 2018 Sune Dandanell and Mikkel Traun
How to manage changes to CDISC standards at Novo Nordisk PhUSE EU Connect 2018 Sune Dandanell and Mikkel Traun How to manage changes to CDISC standards at Novo Nordisk 06-Nov-2018 2 How to manage changes
More informationI, Mary M. Langman, Director, Information Issues and Policy, Medical Library Association
I, Mary M. Langman, Director, Information Issues and Policy, Medical Library Association (MLA), submit this statement on behalf of MLA and the Association of Academic Health Sciences Libraries (AAHSL).
More informationThe Potential of SNOMED CT to Improve Patient Care. Dec 2015
The Potential of SNOMED CT to Improve Patient Care stephen.spencer@nhs.net stephen.spencer@nhs.net Dec 2015 What is SNOMED CT SNOMED CT: Is the most comprehensive, multilingual clinical healthcare terminology
More informationBest Practices for Using LOINC
PCORnet Best Practices Sharing Session Best Practices for Using LOINC Daniel J. Vreeman, PT, DPT, MSc Associate Research Professor, Indiana University School of Medicine Associate Director for Terminology
More informationInspector's Accreditation Unit Activity Menu
01/12/20XX 15:58:57 Laboratory Accreditation Program Page 1 of 9 CHEMISTRY 1501 ALT, serum/plasma 1502 Albumin, serum/plasma 1504 Alkaline phosphatase, serum/plasma 1506 Amylase, serum/plasma 1508 Bilirubin,
More informationHOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR
HOUSE OF REPRESENTATIVES STAFF ANALYSIS BILL #: HB 1619 Clinical Laboratories SPONSOR(S): Garcia TIED BILLS: IDEN./SIM. BILLS: SB 2182 REFERENCE ACTION ANALYST STAFF DIRECTOR 1) Health Care Regulation
More informationJoint ADA and Health Level 7 Collaboration On Electronic Dental Attachments
Joint ADA and Health Level 7 Collaboration On Electronic Dental Attachments Jean Narcisi, Director, Department of Dental Informatics Patrick Cannady, Manager, Department of Dental Informatics ADA Practice
More informationMoving Family Health History & Genetic Test Result Data into the Electronic Health Record for Clinical Decision Support
Moving Family Health History & Genetic Test Result Data into the Electronic Health Record for Clinical Decision Support HL7 30 Years of Standards Development HIMSS February 21, 2017 Grant M. Wood Intermountain
More informationAPHL-PHDSC Collaboration Standards in the laboratory realm
APHL-PHDSC Collaboration Standards in the laboratory realm November 9 th, 2012 PHDSC Annual Meeting Riki Merrick, MPH Contractor to Association of Public Health Laboratories Overview Collaboration between
More informationAnthem Blue Cross and Blue Shield Commercial Professional Reimbursement Policy
Subject: Laboratory and Venipuncture Services ME Policy: 0029 Effective: 08/22/2016 03/31/2017 Coverage is subject to the terms, conditions, and limitations of an individual member s programs or products
More informationCDISC CONTROLLED TERMINOLOGY. Presented by Chris Gemma and Erin Muhlbradt, Ph.D.
1 CDISC CONTROLLED TERMINOLOGY Presented by Chris Gemma and Erin Muhlbradt, Ph.D. CDISC 2018 2 Question & Answer Panelist : Question OR Presentation : Question Examples: 1) What should be supported by
More informationPENN STATE MILTON S. HERSHEY MEDICAL CENTER TABLE OF CRITICAL LAB VALUES CURRENT AS OF: 1/2015
PENN STATE MILTON S. HERSHEY MEDICAL CENTER TABLE OF CRITICAL LAB VALUES CURRENT AS OF: 1/2015 Section: Chemistry For inpatients, once 3 consecutive critical values for the same analyte (test result) have
More informationWELSH INFORMATION STANDARDS BOARD
WELSH INFORMATION STANDARDS BOARD DSC Notice: DSCN 2018 / 06 Date of Issue: 8 th August 2018 Welsh Health Circular / Official Letter: (2015) 053 Subject: CT Maturity Matrix Sponsor: Chris Newbrook, Head
More informationBuilding a Diseases Symptoms Ontology for Medical Diagnosis: An Integrative Approach
Building a Diseases Symptoms Ontology for Medical Diagnosis: An Integrative Approach Osama Mohammed, Rachid Benlamri and Simon Fong* Department of Software Engineering, Lakehead University, Ontario, Canada
More informationDisclosures. Relevant Financial Relationship(s): Nothing to Disclose. Off Label Usage: Nothing to Disclose 9/19/2017. Proficiency Testing
September 11, 2017 Teri Ross, Quality Specialist II Doreen Ryan, MA, MT; Quality Operations Supervisor Deborah J. Wells, MPA, MT(ASCP)SH, Quality Management Coordinator Disclosures Relevant Financial Relationship(s):
More informationHUMAN IMMUNODEFICIENCY VIRUS (HIV) NON-IMMEDIATE NOTIFICATION STD PROGRAM. Version
1 HUMAN IMMUNODEFICIENCY VIRUS (HIV) NON-IMMEDIATE NOTIFICATION STD PROGRAM Event Name: Event Time Period: ADULT HIV 900 (AIDS.gov 12/31/2015) HIV Lifelong HIV (human immunodeficiency virus) is a retrovirus
More information2014 Notice to Physicians
2014 Notice to Physicians August 20, 2014 Dear Physician, will only pay for tests that are deemed medically necessary. These regulations impact physicians who order the tests as well as the laboratories
More informationThe National Vaccine Advisory Committee: Reducing Patient and Provider Barriers to Maternal Immunizations
The National Vaccine Advisory Committee: Reducing Patient and Provider Barriers to Maternal Immunizations Executive Summary Maternal immunization provides important health benefits for pregnant women and
More informationA Study on a Comparison of Diagnostic Domain between SNOMED CT and Korea Standard Terminology of Medicine. Mijung Kim 1* Abstract
, pp.49-60 http://dx.doi.org/10.14257/ijdta.2016.9.11.05 A Study on a Comparison of Diagnostic Domain between SNOMED CT and Korea Standard Terminology of Medicine Mijung Kim 1* 1 Dept. Of Health Administration,
More informationUniCare Professional Reimbursement Policy
UniCare Professional Reimbursement Policy Subject: Laboratory and Venipuncture Services Policy #: UniCare 0029 Adopted: 02/02/2010 Effective: 08/31/2017 Coverage is subject to the terms, conditions, and
More informationHealtheNet Pathology - overview
HealtheNet Pathology - overview Joshua Bunting HealtheNet Integration Manager - ehealth NSW Alex Eigenstetter Director of Performance NSW Health Pathology August 2017 1 A de-identified patient case study
More informationUpdate to the Human Leukocyte Antigens (HLA) Equivalency Tables
Update to the Human Leukocyte s (HLA) Equivalency Tables Sponsoring Committee: Histocompatibility Policy/Bylaws Affected: Policy 2.11.A: Required Information for Deceased Kidney Donors, Policy 2.11.B:
More informationSNOMED CT in General Practice systems
SNOMED CT in General Practice systems Overview for Commissioners: Session 1 presented by Denise Downs, Senior Terminology Implementation Specialist Agenda First of 2 sessions, Session 2 walks through SNOMED
More informationCDISC - Mapping New Pathways for Novartis. Darren Weston, Project Leader Pat Majcher, Senior Principal Programmer
CDISC - Mapping New Pathways for Novartis Darren Weston, Project Leader Pat Majcher, Senior Principal Programmer Shuhong hong Xie, Senior Statistical Programmer Agenda What was the submission request?
More information35.0. ug/ml Trough. 8.0 Carbamazepine 15.0 ug/ml Digoxin 2.5 ng/ml Gentamicin Peak Random Trough
The following are a list by department of Critical (Panic) Values: CHEMISTRY TEST LESS THAN GREATER THAN UNITS Glucose 0-7days 40 200 mg/dl Glucose > 7 days 50 400 mg/dl Glucose, CSF 25 mg/dl Sodium 121
More informationDESCRIPTION: Percentage of new patients whose biopsy results have been reviewed and communicated to the primary care/referring physician and patient
Quality ID #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination Meaningful Measure Area: Transfer of Health Information and Interoperability 2019 COLLECTION TYPE:
More informationTHE PHLIP ADVANTAGE ~Moving our Labs forward in data exchange~
THE PHLIP ADVANTAGE ~Moving our Labs forward in data exchange~ The PHLIP BIG Picture Patina Zarcone, MPH Director of Informatics & KM PHLIP Steering Committee Member What We Know Laboratory Data is Vital
More informationM.D.IPA, M.D.IPA Preferred, Optimum Choice and Optimum Choice Preferred STAT Laboratory List Revised Jan. 5, 2017
M.D.IPA, M.D.IPA Preferred, Optimum Choice and Optimum Choice Preferred STAT Laboratory List Revised Jan. 5, 2017 If laboratory results are required on a STAT basis, the designated commercial medical laboratory
More informationThe findings and conclusions in this presentation
The findings and conclusions in this presentation formall disseminated by b the have not been formally Centers for Disease Control and Prevention and should not be construed to represent any agency p y
More informationPatient characteristics associated with venous thromboembolic events: a cohort study using pooled electronic health record data
Patient characteristics associated with venous thromboembolic events: a cohort study using pooled electronic health record data Kaelber, et al, JAMIA, 3 July 2012 David C Kaelber, MD, PhD, MPH, FAAP, FACP
More information5/22/2013. Alan Zuckerman 1, Swapna Abhyankar 1, Tiffany Colarusso 2, Richard Olney 2, Kristin Burns 3, Marci Sontag 4
Alan Zuckerman 1, Swapna Abhyankar 1, Tiffany Colarusso 2, Richard Olney 2, Kristin Burns 3, Marci Sontag 4 1 National Library of Medicine, NIH, Bethesda, MD, USA, 2 Centers for Disease Control and Prevention,
More informationAUSTRALIAN PATHOLOGY UNITS AND TERMINOLOGY (APUTS) Harmonised Reference Intervals Chemical Pathology. (v1.1)
AUSTRALIAN PATHOLOGY UNITS AND TERMINOLOGY (APUTS) Harmonised Reference Intervals Chemical Pathology (v1.1) ISBN: Pending 1 State Health Publication Number (SHPN): Pending Online copyright RCPA 2014 This
More informationProject Charter. Template v2 June 3, February 25, Name of Project: Prostate Cancer (PrCa) Therapeutic Area Data Standards
Project Charter Template v2 June 3, 2015 Name of Project: Prostate Cancer (PrCa) Therapeutic Area Data Standards February 25, 2016 Project Manager: John Owen 1. Scope of Prostate Cancer Therapeutic Area
More informationInstitute of Medicine Workshop: DIGITAL DATA PRIORITIES FOR CONTINUOUS LEARNING IN HEALTH AND HEALTH CARE
Institute of Medicine Workshop: DIGITAL DATA PRIORITIES FOR CONTINUOUS LEARNING IN HEALTH AND HEALTH CARE Data Quality in Clinical Research 23 March 2012 Rebecca D. Kush, PhD President and CEO, CDISC CDISC
More informationIntegration of Oral Health Diagnostic Codes in Safety Net Dental Programs. October 25, 2011
Integration of Oral Health Diagnostic Codes in Safety Net Dental Programs October 25, 2011 Integration of Oral Health Diagnostic Codes in Safety Net Dental Programs Dr. Jay R. Anderson Director for Practice
More informationResults that require action
Following is a list of Allina Health Laboratory Results That Require Action (formerly Critical Values). Results That Require Action describes a lab test result that may indicate a lifethreatening situation.
More informationContractor Name: Novitas Solutions, Inc. Contractor Number: Contractor Type: MAC B. LCD ID Number: L34834 Status: A-Approved
LCD for Blood Glucose Monitoring in a Skilled Nursing Facility (SNF) (L34834) Contractor Name: Novitas Solutions, Inc. Contractor Number: 12502 Contractor Type: MAC B LCD ID Number: L34834 Status: A-Approved
More informationPosition Statement Template
Submission Date: 7/6/2005 Committee: Infectious Diseases 05-ID-07 Position Statement Template Title: Revision of the Enterohemorrhagic Escherichia coli (EHEC) condition name to Shiga toxin-producing Escherichia
More informationSurveillance and SEER Where are we going? NAACCR Meeting June 23, 2017 Lynne Penberthy MD, MPH
Surveillance and SEER Where are we going? NAACCR Meeting June 23, 2017 Lynne Penberthy MD, MPH Presentation Objectives Describe Future Role of Registries & Registrars Challenges to cancer surveillance
More informationQPP/MIPS Success with Longitudinal Quality Measurement
QPP/MIPS Success with Longitudinal Quality Measurement Session #299, March 9, 2018 Laura McCrary, Executive Director, KHIN John D Amore, President, Diameter Health 1 Conflict of Interest Laura McCrary,
More informationQuality ID #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination
Quality ID #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION: Percentage
More informationIU Health Pathology Laboratory. DOS Updates
IU Health Pathology Laboratory News Bulletin February 23, 2012 DOS Updates Apolipoprotein B QN Ship refrigerated plasma instead of frozen; Frozen plasma is acceptable however. Myoglobin, Serum Discontinued
More informationNational Program of Cancer Registries Advancing E-cancer Reporting and Registry Operations (NPCR-AERRO): Activities Overview
National Program of Cancer Registries Advancing E-cancer Reporting and Registry Operations (NPCR-AERRO): Activities Overview Sandy Jones Public Health Advisor NAACCR 2011 Conference June 22, 2011 National
More informationOVERVIEW. Denver International Airport 1
OVERVIEW Introduction Denver International Airport ( DEN or Airport ) is a large hub airport serving 58.3 million passengers each year through 572,520 (2016) operations (landings and takeoffs). It is the
More informationDENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period
Measure #48: Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR
More informationIRB Policy 5 Research Activities
IRB Policy 5: Research Activities Revision Date: April 16, 2008, revision 12/23/09, revised 1/5/2010, revised January 27, 2011, revised January 14, 2016, revised April 2, 2018, revised 9/14/18 I. Definitions:
More informationSAGE. Nick Beard Vice President, IDX Systems Corp.
SAGE Nick Beard Vice President, IDX Systems Corp. Sharable Active Guideline Environment An R&D consortium to develop the technology infrastructure to enable computable clinical guidelines, that will be
More informationAgenda. Immunization Registry Reporting in Community Health Centers. Presented by: Ben Pierson Program Manager Health Information Exchange
Immunization Registry Reporting in Community Health Centers Presented by: Ben Pierson Program Manager Health Information Exchange Agenda Introduction About OCHIN Vaccination support in EHR Immunization
More informationAppendix E: Limited English Proficiency Plan What s in our LEP Plan?
Appendix E: Limited English Proficiency Plan What s in our LEP Plan? Content related to planning for LEP populations from the Title VI Nondiscrimination Plan (2018 Update) Limited English Proficient Households
More informationQuality ID#164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clincial Care
Quality ID#164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clincial Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE
More informationStandards for Pathology Informatics in Australia (SPIA)
Standards for Pathology Informatics in Australia (SPIA) Reporting Terminology and Codes Chemical Pathology (v3.0) Superseding and incorporating the Australian Pathology Units and Terminology Standards
More informationCDISC Controlled Terminology. Presented by Chris Gemma and Erin Muhlbradt, Ph.D.
CDISC Controlled Terminology Presented by Chris Gemma and Erin Muhlbradt, Ph.D. Panelists Erin Muhlbradt, Clincal/Biomedical Information Specialist, MSC Chris Gemma, Project Manager, CDISC 2 Question &
More informationAssessing Drug Safety
Assessing Drug Safety Paul J. Seligman, MD, MPH Director Office of Pharmacoepidemiology & Statistical Science Center for Drug Evaluation & Research July 20, 2005 Institute of Medicine Committee 1 Agenda
More informationPROPOSED WORK PROGRAMME FOR THE CLEARING-HOUSE MECHANISM IN SUPPORT OF THE STRATEGIC PLAN FOR BIODIVERSITY Note by the Executive Secretary
CBD Distr. GENERAL UNEP/CBD/COP/11/31 30 July 2012 ORIGINAL: ENGLISH CONFERENCE OF THE PARTIES TO THE CONVENTION ON BIOLOGICAL DIVERSITY Eleventh meeting Hyderabad, India, 8 19 October 2012 Item 3.2 of
More informationNational Drug Abuse Treatment Clinical Trials Network. October 5, 2011
NID A NATIONAL INSTITUTE ON DRUG ABUSE National Drug Abuse Treatment Clinical Trials Network October 5, 2011 Betty Tai, Ph.D. Director, Center for the Clinical Trials Network NIDA/NIH/DHHS Measuring Performance
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Chen CL, Lin GA, Bardach NS, et al. Preoperative medical testing
More informationDENOMINATOR: All patients, regardless of age, with a diagnosis of inflammatory bowel disease who initiated an anti-tnf agent
Quality ID #275: Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy National Quality Strategy Domain: Effective Clinical
More informationThe Standard for the Exchange of Nonclinical Data (SEND): History, Basics, and Comparisons with Clinical Data
Life Sciences Accelerated R&D Services The Science of Getting Products to Patients Faster The Standard for the Exchange of Nonclinical Data (SEND): History, Basics, and Comparisons with Clinical Data Fred
More informationUsing Blood Glucose Meters in the Hospital: Defining Critically Ill and Addressing Accreditation Issues
Using Blood Glucose Meters in the Hospital: Defining Critically Ill and Addressing Accreditation Issues Stephen E. Kahn, PhD, DABCC, FACB Professor and Vice Chair, Clinical Services, Pathology Loyola University
More informationClinical decision support (CDS) and Arden Syntax
Clinical decision support (CDS) and Arden Syntax Educational material, part 1 Medexter Healthcare Borschkegasse 7/5 A-1090 Vienna www.medexter.com www.meduniwien.ac.at/kpa (academic) Better care, patient
More informationDesign and Construct Efficacy Analysis Datasets in Late Phase Oncology Studies
PharmaSUG China Design and Construct Efficacy Analysis s in Late Phase Oncology Studies Huadan Li, MSD R&D (China) Co., Ltd., Beijing, China Changhong Shi, MSD R&D (China) Co., Ltd., Beijing, China ABSTRACT
More informationCase Log Number(s) Veterinarian or VTS Accurately report test results, using appropriate units of measurement Quality Control/Assurance Date Mastered
AVCPT Skills List Candidate: Understanding of test methodology, techniques and ability to perform testing must be applied to each skill. The overall goal is to provide accurate and valid results to assist
More information2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Measure #275: Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy National Quality Strategy Domain: Effective Clinical
More informationEHR Developer Code of Conduct Frequently Asked Questions
EHR Developer Code of Conduct Frequently Asked Questions General What is the purpose of the EHR Developer Code of Conduct? EHR Association (the Association) members have a long tradition of working with
More informationCommon Data Elements: Making the Mass of NIH Measures More Useful
Common Data Elements WG Common Data Elements: Making the Mass of NIH Measures More Useful Jerry Sheehan Assistant Director for Policy Development Na?onal Library of Medicine Gene/c Alliance Webinar Series
More informationUnderstanding Blood Tests
PATIENT EDUCATION patienteducation.osumc.edu Your heart pumps the blood in your body through a system of blood vessels. Blood delivers oxygen and nutrients to all parts of the body. It also carries away
More informationRebooting Cancer Data Through Structured Data Capture GEMMA LEE NAACCR CONFERENCE JUNE, 2017
Rebooting Cancer Data Through Structured Data Capture GEMMA LEE NAACCR CONFERENCE JUNE, 2017 Acknowledgement Richard Moldwin, MD, PhD, CAP Sandy Jones, CDC Wendy Blumenthal, CDC David Kwan, Cancer Care
More informationPathology the missing link in global health care delivery Quentin Eichbaum
Pathology the missing link in global health care delivery Quentin Eichbaum MD, PhD, MPH, MFA, MMHC, JD, BSc(Med)(Hons), BA(Hons), FCAP, FASCP Professor or Pathology, Microbiology and Immunology Professor
More informationAdd your company slogan LOGO
Add your company slogan LOGO Add your company slogan LOGO Louisiana State University Health Sciences Center Results of specimen that is out of normal range and probably is associated with high mortality
More informationAmerican Society for Automation in Pharmacy January 25, 2013
American Society for Automation in Pharmacy January 25, 2013 Presentation by W. Gregory Feero, M.D., Ph.D. Maine Dartmouth Family Medicine Residency Contributing editor, Journal of the American Medical
More informationFREEDOM OF INFORMATION SUMMARY
Date of Approval Letter: September 29, 2000 FREEDOM OF INFORMATION SUMMARY NEW ANIMAL DRUG APPLICATION NADA 141-147 Combination of DECCOX AND CHLORMAX in Cattle Feed (decoquinate and chlortetracycline)
More informationQuality ID #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health
Quality ID #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE
More informationDefinition: Active injection drug users - Those who have injected any drug(s) within the 12 month reporting period
Quality ID #387 (NQF 3060): Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug Users National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL
More informationMedicare & Medicaid EHR Incentive Programs
Medicare & Medicaid EHR Incentive Programs Stage 2 NPRM Overview Robert Anthony March 6, 2012 Proposed Rule Everything discussed in this presentation is part of a notice of proposed rulemaking (NPRM).
More informationMeasure #69 (NQF 0380): Hematology: Multiple Myeloma: Treatment with Bisphosphonates National Quality Strategy Domain: Effective Clinical Care
Measure #69 (NQF 0380): Hematology: Multiple Myeloma: Treatment with Bisphosphonates National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE
More informationQuality ID #6 (NQF 0067): Coronary Artery Disease (CAD): Antiplatelet Therapy National Quality Strategy Domain: Effective Clinical Care
Quality ID #6 (NQF 0067): Coronary Artery Disease (CAD): Antiplatelet Therapy National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process
More informationUsing LOINC and HL7 to standardize hemoglobinopathy screening result reporting
Using LOINC and HL7 to standardize hemoglobinopathy screening result reporting Swapna Abhyankar, MD November 8, 2011 Swapna Abhyankar 1 Brad Therrell 2 Roger Eaton 3 Carla Cuthbert 4 Jelili Ojodu 5 Sara
More informationGuidance for Industry
MEDICAL DEVICES SECTOR Guidance for Industry Format and Content of Proposed Bundling/Grouping Criteria for Medical Devices DRAFT GUIDANCE This guidance document is being distributed for comment purposes
More informationDENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period
Measure #48: Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR
More informationInfluenza-Associated Pediatric Deaths Case Report Form
STATE USE ONLY DO NOT SEND INFORMATION IN THIS SECTION TO CDC Form approved OMB No. 0920-0007 Last Name: First Name: County: Address: City: State, Zip: Patient Demographics 1. State: 2. County: 3. State
More informationFDA s Patient-Focused Drug Development Initiative
FDA s Patient-Focused Drug Development Initiative Theresa M Mullin, PhD Director, Office of Planning and Informatics FDA Center for Drug Evaluation and Research April 24, 2013 Drug Benefit-Risk Assessment
More informationPediatric Oral Healthcare Exploring the Feasibility for E-Measures December 2012
Pediatric Oral Healthcare Exploring the Feasibility for E-Measures December 2012 Copyright 2012 American Dental Association on behalf of the Dental Quality Alliance (DQA). All rights reserved. Use by individuals
More informationPROFICIENCY TESTING. Clinical Laboratory Improvement Amendments (CLIA) DOs and DON Ts. Brochure # 8
Clinical Laboratory Improvement Amendments (CLIA) Brochure # 8 PROFICIENCY TESTING DOs and DON Ts NOTE: Congress passed the Clinical Laboratory Improvement Amendments (CLIA) in 1988 establishing quality
More information9/15/2017. Joyce Turner RN Director of Clinical Program Development
Joyce Turner RN Director of Clinical Program Development A toxic response to an infection that spirals out of control attacking the body s own organs and tissues. The infection can be bacterial, viral
More informationQuality ID #225 (NQF 0509): Radiology: Reminder System for Screening Mammograms National Quality Strategy Domain: Communication and Care Coordination
Quality ID #225 (NQF 0509): Radiology: Reminder System for Screening Mammograms National Quality Strategy Domain: Communication and Care Coordination 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
More informationTherapeutic and Critical Drug Levels
6 Results Reporting As a convenience for our clients and their patients, result reports are printed daily at your facility by means of remote printer/fax machine via internet platforms (4Medica, EMR, ecare/mdoffice)
More informationSage Program Reimbursement Rates (Effective Jan 1, 2018 through Dec 31, 2018)
Sage Program Reimbursement Rates Code Description of Service Allowable Rates New Patient 99201 History, exam, straight forward decision-making; 10 $44.47 99202 Expanded history; exam, straightforward decision-making;
More informationCMS EHR Incentive Program: Proposed Rules for Stage 2 and Stage 3 Meaningful Use Focus on Eligible Hospitals
CMS EHR Incentive Program: Proposed Rules for Stage 2 and Stage 3 Meaningful Use Focus on Eligible Hospitals April 28, 2015 Hosted by: Sponsored by: Today s Event Sponsored By One of the nation s largest
More information2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process
Measure #226 (NQF 0028): Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention National Quality Strategy Domain: Community / Population Health 2017 OPTIONS FOR INDIVIDUAL MEASURES:
More information1. HISTORY. This issue publishes a revision of this publication.
*MEDDAC MEMO 40-138 DEPARTMENT OF THE ARMY US ARMY MEDICAL DEPARTMENT ACTIVITY Fort Huachuca, Arizona 85613-7079 MEDDAC MEMORANDUM 16 August 2006 40-138 Medical Services FOLLOW-UP OF ABNORMAL TEST RESULTS
More informationEMBASE Find quick, relevant answers to your biomedical questions
EMBASE Find quick, relevant answers to your biomedical questions Piotr Golkiewicz Solution Sales Manager Life Sciences Central and Eastern Europe and Russia Embase is a registered trademark of Elsevier
More informationDENOMINATOR: All patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis
Quality ID #401: Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY
More informationNUMERATOR: Reports that include the pt category, the pn category and the histologic grade
Quality ID #99 (NQF 0391): Breast Cancer Resection Pathology Reporting: pt Category (Primary Tumor) and pn Category (Regional Lymph Nodes) with Histologic Grade National Quality Strategy Domain: Effective
More informationNCI Cancer Moonshot. Christine Siemon National Cancer Institute, NIH. November 30, 2017
NCI Cancer Moonshot Christine Siemon National Cancer Institute, NIH November 30, 2017 Presidential Memo 2016 Overall Goals of the Cancer Moonshot Accelerate progress in cancer, including prevention & screening
More information